Crewe Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16
Closed -$2K 293
2019
Q3
$2K Hold
16
﹤0.01% 209
2019
Q2
$1K Hold
16
﹤0.01% 298
2019
Q1
$2K Hold
16
﹤0.01% 223
2018
Q4
$1K Hold
16
﹤0.01% 225
2018
Q3
$1K Sell
16
-545
-97% -$48.2K ﹤0.01% 233
2018
Q2
$45K Buy
561
+90
+19% +$7.47K 0.04% 129
2018
Q1
$42K Sell
471
-45
-9% -$4.32K 0.04% 128
2017
Q4
$54K Buy
+516
New +$58.2K 0.05% 108

Other funds holding CELG

Crewe Advisors's CELG Position: Q4 2019 in Review

Crewe Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16 shares — an estimated $2K sold.

Crewe Advisors first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $54K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Crewe Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Crewe Advisors sold 16 Celgene Corp shares in Q4 2019, an estimated $2K.
  • Crewe Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Crewe Advisors's Celgene Corp position peaked at $54K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Crewe Advisors's 13F filing for Q4 2019, filed 5 Feb 2020.